IL6 and COVID-19: A study conducted by Blanco-Melo et al. [14] showed a transcriptional feature with a high expression of chemokines and IL-6 juxtaposed to reduced innate immune response and low levels of type I and III interferons in tissues from COVID-19 patients and 0.2 MOI-infected cells (Calu-3 and A549).